Antibiotic-Resistant Superbugs Could Kill a Million Chinese a Year

China faces a million deaths a year from antibiotic-resistant superbugs and a loss of $20 trillion by 2050 and these issue doesn't distinguish between religion, color or race.

An economist and former top Goldman Sachs executive said that China faces a million deaths a year from antibiotic-resistant superbugs and a loss of $20 trillion by 2050.

Beijing should "take ownership" of anti-microbial resistance (AMR) when it hosts the G20 summit next year, said Jim O’Neill, the leader of a British government-commissioned review on the subject. "Here is an issue that doesn’t distinguish between religion, color, race," he said. "Whether you’re Sunni or Shiite, you’re going to get killed by AMR if we don’t do something about it."

Antibiotic-Resistant Strains of Bacteria Becoming Superbugs
Two genes that confer resistance against a particularly strong class of antibiotics can be shared easily among a family of bacteria, shows a new study.

O’Neill, former chief economist at the US investment bank and chairman of Goldman Sachs Asset Management, said that the threat put China’s remarkable economic performance in the last decade and its enormous future potential in jeopardy. "Drug-resistant infections could cost the Chinese economy 20 trillion USD by 2050, and even more shockingly, cause an additional 1 million deaths per year," he said.

The review, announced last year by British Prime Minister David Cameron, has found that by 2050, drug-resistant infections could cut global gross domestic product by 2.0 to 3.5% and kill 10 million people a year around the world.

In comparison the second-biggest killer, cancer, would account for about 8.2 million deaths a year by 2050, according to the review.

Unchecked Drug-Resistant Superbugs can Kill 10m Per Yr
Unchecked drug-resistant superbugs can kill 10 million a year and cost the global economy up to 100 trillion dollars by 2050, reveals a new study.

Several novel diseases have emerged from China in recent years, including Severe Acute Respiratory Syndrome (SARS) and human outbreaks of different strains of bird flu.

Beijing has come under criticism in the past for its state-run hospital system, in which medical institutions are heavily dependent on antibiotics sales for their revenue.

New Treatment Proves Effective Against Antibiotic-Resistant 'Superbugs'
A new treatment is far more effective than traditional antibiotics at inhibiting the growth of drug-resistant bacteria, including so-called superbugs resistant to almost all existing antibiotics, which plague hospitals and nursing homes.

Experts say the system incentivises doctors to prescribe unnecessary antibiotics, thus exacerbating the problem of drug resistance.

O’Neill -- who is known for having coined the BRIC acronym to refer to emerging powers Brazil, Russia, India and China -- acknowledged the issue, telling reporters: "You’ve got to think of better ways of compensating the medical profession."

�Superbugs� Getting Stronger: Antibiotics Failing to Resist Bacteria
The overuse of antibiotics in hospitals and our farms is causing trouble in fighting bacteria.

Source-AFP